Portfolio company
Toralgen
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biopharmaceutical company develops nanoparticle technology for the oral delivery of biologics and diabetes medications for pharmaceutical partners and patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Biograil
This biotech company develops a capsule device that enables oral delivery of injectable biologic drugs for pharmaceutical firms and patients.
Exolvo
This company develops smart capsules using dissolvable microneedles for the oral delivery of biologic drugs to pharmaceutical partners and patients.
Calyx Therapeutics
This company develops oral therapies for diabetes and inflammatory diseases using natural plant extracts for pharmaceutical and biotechnology organisations.
DiogenX
This biotech company develops recombinant proteins designed to regenerate insulin-producing pancreatic beta cells for patients with type 1 diabetes.
Emulsi Biotech
Emulsi Biotech develops lipid-based oral drug delivery platforms to enable pharmaceutical companies to administer complex biological therapies through capsules instead of injections.
Exolvo Biosciences
Exolvo Biosciences develops oral smart capsules for the delivery of biologic drugs to pharmaceutical companies and patients.
General Biotechnologies
This company develops genetically programmed edible microbes to manufacture oral peptide therapeutics for patients with metabolic diseases and other chronic conditions.
Tolergyx
This company develops gastrointestinal immunotherapy capsules to treat food allergies in pediatric and adult patients.
